DVA
DaVita HealthCare Partners Inc
NYSE: DVA · HEALTHCARE · MEDICAL CARE FACILITIES
$155.14
+2.07% today
Updated 2026-04-30
Market cap
$9.90B
P/E ratio
15.78
P/S ratio
0.73x
EPS (TTM)
$9.51
Dividend yield
—
52W range
$101 – $159
Volume
0.8M
DaVita HealthCare Partners Inc (DVA) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$155.14
12-Month target
$153.33
2030 Target
—
Intrinsic (DCF)
$250.75
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.6B | $11.6B | $12.1B | $12.8B | $13.6B | $14.1B | $14.6B | $15.1B | $15.6B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 3.39% (capped 20%) · P/E: 15.78x (capped 25x) · Margin: 5.47%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.